Results and analysis from the Symplicity Flex trial of renal denervation and the CoreValve High Risk trial will be among the research discussed at next month's Transcatheter Cardiovascular Therapeutics Scientific Symposium. Other research addressing the practice of interventional cardiology includes a five-year look at TAVR, an evaluation of clopidogrel and various stent trials.

Related Summaries